Hospital
Monroe Surgical Hospital, LLC
Monroe Surgical Hospital, LLC was paid $797K by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 43239, Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple — 27% of everything it billed.
33Billing provider infoMONROE SURGICAL HOSPITAL, LLC
MONROE, LA 71201
MONROE, LA 71201
33aNPI1225031495assigned 05/23/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$797K
24GClaims20,107
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#67 of 96
Median peer was paid$5.17M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 457 | $11K | |
| 2019 | 602 | $8K | |
| 2020 | 705 | $27K | |
| 2021 | 4,166 | $122K | |
| 2022 | 6,273 | $273K | |
| 2023 | 5,213 | $247K | |
| 2024incomplete | 2,691 | $109K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 27% | 592 | 530 | $216K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 19% | 269 | 206 | $155K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 9.9% | 1,053 | 960 | $79K |
| V2632 | Posterior chamber intraocular lens | 8.6% | 573 | 457 | $68K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 5.4% | 92 | 86 | $43K |
| 93017 | 4.9% | 789 | 720 | $39K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.8% | 1,117 | 1,005 | $38K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4.0% | 240 | 216 | $32K |
| 80050 | General health panel | 2.6% | 554 | 504 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 2,904 | 2,444 | $20K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.3% | 160 | 139 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 686 | 597 | $10K |
38 more codes
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1.1% | 358 | $9K |
| 80061 | Lipid panel | <1% | 603 | $7K |
| 76830 | Ultrasound, transvaginal | <1% | 115 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 420 | $6K |
| 93270 | <1% | 123 | $5K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $5K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 170 | $4K |
| 73564 | <1% | 233 | $4K | |
| 73630 | <1% | 79 | $4K | |
| 73130 | <1% | 81 | $4K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 114 | $3K |
| 70220 | <1% | 203 | $2K | |
| 74018 | <1% | 151 | $1K | |
| 73562 | <1% | 49 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,538 | $507.92 |
| 93246 | <1% | 23 | $464.20 | |
| 72100 | <1% | 17 | $399.36 | |
| 87807 | <1% | 26 | $314.40 | |
| 82962 | <1% | 100 | $291.78 | |
| 70360 | <1% | 14 | $240.89 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,178 | $155.62 |
| 81003 | <1% | 72 | $137.35 | |
| 85027 | <1% | 202 | $61.27 | |
| 85730 | <1% | 171 | $42.07 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 250 | $31.33 |
| 85610 | <1% | 171 | $30.03 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 33 | $29.70 |
| 81025 | <1% | 194 | $24.45 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 61 | $16.92 |
| 82948 | <1% | 12 | $4.07 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 588 | $0.75 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 175 | $0.38 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,034 | $0.37 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 131 | $0.00 |
| J3490 | Unclassified drugs | 0% | 270 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 14 | $0.00 |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | 0% | 16 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 76 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHEMPHILL, ROBYN (CEO/DON)
| Provider | Location | Paid |
|---|---|---|
| Monroe Surgical Hospital, LLC | Mangham, LA | $1.09M |
| Monroe Surgical Hospital | Monroe, LA | $19K |
| Monroe Surgical Hospital, LLC | Mangham, LA | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.